id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-N-6476-0001,FDA,FDA-2017-N-6476,Pediatric Rare Diseases-A Collaborative Approach for Drug Development Using Gaucher Disease as a Model; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2017-12-07T05:00:00Z,2017,12,2017-12-07T05:00:00Z,2018-02-06T04:59:59Z,2018-02-06T02:04:23Z,2017-26357,0,0,0900006482ced510
FDA-2017-N-6476-0002,FDA,FDA-2017-N-6476,Draft Guidance for Industry Pediatric Rare Diseases-A Collaborative Approach for Drug Development Using Gaucher Disease as a Model,Other,Guidance,2017-12-07T05:00:00Z,2017,12,2017-12-07T05:00:00Z,,2024-11-07T01:13:39Z,,1,0,0900006482ced412